Lot BPCTB072026-MG
99.8%
Overall purity
Tested July 13, 2026
Open COAFOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
Before you continue
This site sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
BPC Wolverine (10mg / 10mg) is a lyophilized research blend of two synthetic peptides, BPC-157 and TB-500, supplied by Peppy Peptides for laboratory research use only. BPC Wolverine is studied in laboratory research for its interaction with cellular-signaling pathways and tissue-level biological processes.
BPC Wolverine is Peppy Peptides' name for a research-grade blend that combines two separately characterized peptides:
This listing supplies BPC Wolverine in the 10mg / 10mg format. BPC Wolverine is intended only for qualified researchers working in a controlled laboratory environment.
Researchers studying tissue-repair signaling frequently include BPC-157 in laboratory models, examining its interaction with cellular-signaling pathways in in-vitro cell models and in-vivo research models. BPC-157 is also studied in gastrointestinal-tissue signaling models, reflecting its originally identified biological source. TB-500 is referenced in cytoskeletal and cell-migration research models for its actin-binding mechanism.
As a combined formulation, BPC Wolverine lets researchers examine both pathway families within a single research model, often alongside single-peptide controls for comparison. All applications described here refer only to laboratory research models.
BPC Wolverine combines BPC-157 and TB-500. The identity of both components is documented in the Product Specifications section on this page.
No. BPC Wolverine is supplied for laboratory research use only by qualified researchers working in a controlled laboratory setting.
Published laboratory research on BPC-157 is indexed on PubMed.
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. This compound has not received FDA approval. All information shown is drawn from clinical studies for educational purposes.
Researcher favourites
Price range: $125.00 through $175.00
Price range: $150.00 through $650.00
Price range: $125.00 through $700.00
$150.00
$175.00
Lab-verified quality
Each lot is analysed by Bioviridian before release. Below is the Certificate of Analysis for the most recent lot, as issued by the laboratory.
Overall purity
99.8%
RP-HPLC (214 nm)
View the signed COA (PDF)Check this certificate at bioviridians.com/coa-search.html with code COA7682.
Test results
5 of 5 conformHPLC retention time 9.100, 9.173 min · Signed: Shane Straight, M.S., Principal Chemist, Bioviridian Inc.
Every lot keeps its own signed certificate. Lots are listed newest first.
Lot BPCTB072026-MG
99.8%
Overall purity
Tested July 13, 2026
Open COAEarlier lots will appear here as new Certificates of Analysis are published.
Compound details
Molecular profile
Storage requirements
Store lyophilized BPC Wolverine at −20°C for long-term stability, protected from light and moisture.
Refrigerate at 2–8°C after reconstitution and use within 4–6 weeks; avoid repeated freeze-thaw cycles, keep the vial sealed between uses.
Published literature
4 peer-reviewed publications indexed on PubMed. Listed for reference only; inclusion does not imply any use, effect or endorsement.
CURR PHARM DES · 2014 BPC-157
Seiwerth S, Brcic L, Vuletic LB, et al. Curr Pharm Des. 2014;20(7):1121-5. doi:10.2174/13816128113199990421
Reviewed published laboratory and preclinical research on BPC 157 in relation to blood-vessel biology.
CURR PHARM DES · 2014 BPC-157
Stable gastric pentadecapeptide BPC 157-NO-system relation
Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2014;20(7):1126-35. doi:10.2174/13816128113190990411
Reviewed research on the relationship between BPC 157 and the nitric oxide (NO) system.
NEURAL REGEN RES · 2022 BPC-157
Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, et al. Neural Regen Res. 2022;17(3):482-487. doi:10.4103/1673-5374.320969
Reviewed preclinical research on BPC 157 in relation to the central nervous system.
THE JOURNAL OF BIOLOGICAL CHEMISTRY · 1991 TB-500 / Thymosin beta-4
Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable
Safer D, Elzinga M, Nachmias VT The Journal of biological chemistry. 1991;266(7):4029-32.
Sequenced the platelet actin-sequestering peptide Fx, identified it as thymosin beta-4, and characterized its 1:1 binding to G-actin and inhibition of actin polymerization.